MedTrace Logo

Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

NCT02940366 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2017-02-09

No results posted yet for this study

Summary

This purpose of this study is to evaluate effect of high-dose Pitavastatin on glucose control in patients with metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

DRUG

Pitavastatin 4 mg orally daily

Pitavastatin 4 mg orally daily for 24months

DRUG

Atorvastatin 20 mg orally daily

Atorvastatin 20 mg orally daily for 24months

Sponsors & Collaborators

  • JW Pharmaceutical

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02940366 on ClinicalTrials.gov